1. The company reported $87 million in net income for the fourth quarter of 2014, down from $108 million in the fourth quarter of 2013. The decline in revenue was due to an increase in operating expenses and one-time charges, according to the report.
2. Boston Scientific reported charges of $216 million, post-tax charges for the quarter, up from $182 million in charges for the prior year period.
3. Though profit was down, the company’s sales inched upward 3 percent from $1.89 billion in the fourth quarter of 2013 to $1.84 million in the prior year period.
4. The company’s reported flat sales for its endoscopy service line.
More articles on gastroenterology:
Preparing for potential GI payment cuts: 3 quick tips
Kaiser Permanente Fresno names Dr. Smita Rouillard hospital physician leader
GI physician leader to know: Dr. Geoffrey Braden of G.I. Specialists
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.